Pan Tumor Nivolumab Rollover Study

About the study

Main Objective of this study is to examine long-term safety of nivolumab in participants on treatment and in follow up.

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Inclusion Criteria: -

Signed Written Informed Consent
Participants who have completed treatment with nivolumab, progressed on prior nivolumab treatment or discontinued nivolumab due to toxicity in the Parent Study are not eligible to receive nivolumab in this study. These participants may be enrolled for safety and survival follow-up only.
Participant is eligible for nivolumab treatment as per the Parent Study, and/or Investigator assessed clinical benefit, or

EXCLUSION CRITERIA

Participant is in or has completed the follow-up phase of the Parent Study i) Participant has completed or discontinued treatment, or ii) Participant has progressed on treatment, and/or iii) Participant is on subsequent therapy Exclusion Criteria: -

Participant is not eligible for nivolumab treatment as per the Parent Study

Participants not receiving clinical benefit as assessed by the Investigator (participant is still eligible for study if entering survival follow-up only)

Any clinical adverse event (AE), laboratory abnormality, or intercurrent illness which, in the opinion of the Investigator, indicates that participation in the study is not in the best interest of the participant

Participants in survival follow-up have no exclusion criteria.

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply

Contact the study center to learn if this study is a good match for you.

Study’s details

Contition

Cancer

Age (in years)

18+

Phase

Phase 2

Participants needed

800

Est. Completion Date

Aug 25, 2025

Treatment type

Interventional

Sponsor

Bristol-Myers Squibb

ClinicalTrials.gov identifier

NCT03899155

Study number

CA209-8TT

Understanding Clinical Trials

Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?